Linagliptin, when compared to placebo, improves CD34+ve...

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial

Awal, Hassan B., Nandula, Seshagiri Rao, Domingues, Cleyton C., Dore, Fiona J., Kundu, Nabanita, Brichacek, Beda, Fakhri, Mona, Elzarki, Adrian, Ahmadi, Neeki, Safai, Shauna, Fosso, Magan, Amdur, Rich
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-020-01046-z
Date:
December, 2020
File:
PDF, 1.76 MB
2020
Conversion to is in progress
Conversion to is failed